title: [The use of mexidol in psychiatric practice].
abstract: Mexidol has been used in combination with basic therapy in 65 patients with mental disorders of organic genesis. The patients were treated during 56 days in accordance with a special scheme including the drug intake and intramuscular and intravenous injections. Mexidol exerted a positive effect on affective sphere, normalized the sleep-wake cycle, promoted rehabilitation of cognitive function thus improving the global clinical state of patients. Marked and significant improvement was found in 40,0% and 33,8% of cases, respectively. No severe side-effects were noticed.
authors.forename: V G
authors.initials: VG
authors.lastname: Kosenko
authors.forename: E A
authors.initials: EA
authors.lastname: Karagezian
authors.forename: L V
authors.initials: LV
authors.lastname: Luneva
authors.forename: L F
authors.initials: LF
authors.lastname: Smolenko
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D003071:Cognition / Q000187:drug effects / Q000502:physiology; D004333:Drug Administration Routes; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy* / Q000523:psychology; D008875:Middle Aged; D010847:Picolines / Q000008:administration & dosage / Q000627:therapeutic use*; D012890:Sleep / Q000187:drug effects / Q000502:physiology; D016896:Treatment Outcome
chemical_list: D000975:Antioxidants; D010847:Picolines; C070020:emoxypine succinate